Additionally, survival analysis has revealed that patients with tumor (such as NSCLC, gastric cancer, CRC, and pancreatic cancer) characterized by high GINS4 expression have significantly diminished overall survival (OS) and disease-free survival (DFS) compared with those with lower GINS4 expression (19, 20, 22–24). Here, GINS4 is linked to neoplasm.